33 results
CORRESP
URGN
UroGen Pharma Ltd.
27 Nov 23
Correspondence with SEC
12:00am
by project. Provide other quantitative or qualitative disclosure that provides more transparency as to the type of research and development expenses … quantitative or qualitative disclosure that provides more transparency as to the type of research and development expenses incurred (i.e., by nature or type
UPLOAD
p1dxcrk69g
16 Nov 23
Letter from SEC
12:00am